Athenese-Dx Private Limited, a active private limited company, was established on 24 February 2012 in Chennai, Tamil Nadu, India. Engaging in medical & laboratory equipment within the manufacturing sector, it holds CIN: U85100TN2012PTC084632. Registered under ROC Roc Chennai. it is unlisted. It has an authorized capital of ₹1.00 Cr and a paid-up capital of ₹7.02 M.
It upholds a compliant status. Employing 289 professional, Its leadership includes Arunkumar Chakravarthy (Whole-Time Director), Catherine Yaping Chen (Director), Srikrishnan (Additional Director). Past directors included Balakrishnan Jaikumar, Jeyan Azhagesan, Arunkumar Chakravarthy. It holds no open charges and ₹5.00 M settled loans. Its latest AGM occurred on 21 September 2024, with the balance sheet filed on 31 March 2024. It is based at Module No.407 & 408, 4Th Floor, Ticel Bio Park Ii No.5, Csir Road, Taramani, Chennai, Tamil Nadu, 600113.
U85100TN2012PTC084632
084632
24 February 2012
₹1.00 Cr
₹7.02 M
Roc Chennai
Unlisted
Active
Explore comprehensive insights into Athenese-Dx Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Arunkumar Chakravarthy | Whole-Time Director | 06 Jan 2017 | Current |
| Catherine Yaping Chen | Director | 30 Dec 2020 | Current |
| Srikrishnan | Additional Director | 14 Nov 2025 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Director | 17 Sep 2014 | Past |
| Pramod Abcsdd | Director | 06 Jan 2017 | Past |
| Pramod Abcsdd | Additional Director | 29 Sep 2017 | Past |
| Pramod Abcsdd | Additional Director | 30 Dec 2020 | Past |
| Pramod Abcsdd | Director | 23 Nov 2020 | Past |
| Pramod Abcsdd | Director | 07 Oct 2018 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Athenese-Dx Private Limited, for the financial year ended 2023, experienced Minor drop in revenue, with a 9.63% decrease. The company also saw a substantial fall in profitability, with a 63.84% decrease in profit. The company's net worth Soared by an impressive increase of 16.96%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
In 2023, Athenese-Dx had a promoter holding of 75.97% and a public holding of 24.03%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Reveal ownership structures and financial performance - Get instant access now!
₹0
₹5,000,000.00
| Date | Lender | Amount | Status |
|---|---|---|---|
| 28 May 2020 | Sidbi | ₹5.00 M | Satisfied |
Explore comprehensive loan charge details -
Athenese-Dx has a workforce of 289 employees as of May 11, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Gain comprehensive insights into the Deals and Valuation data of Athenese-Dx, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Athenese-Dx's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
The activity Srikrishnan was appointed as a Additional Director was appointed as a Additional Director on 14 Nov 2025 & has been associated with this company since 1 month 11 days . was completed.
Progress on Athenese-Dx Private Limited last Annual general meeting of members was held on 21 Sep 2024 as per latest MCA records. was documented.
Progress on Athenese-Dx Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Chennai. was documented.
The activity A charge registered on 28 May 2020 via Charge ID 100338474 with Sidbi was fully satisfied on 04 May 2022. was completed.
Progress on Catherine Yaping Chen was appointed as a Director was appointed as a Director on 30 Dec 2020 & has been associated with this company since 4 years 11 months . was documented.
A charge with Sidbi amounted to Rs. 0.50 Cr with Charge ID 100338474 was registered on 28 May 2020. was recorded as a recent event.
The CIN of Athenese-Dx Private Limited is U85100TN2012PTC084632.
Athenese-Dx Private Limited is headquartered at Module No.407 & 408, 4Th Floor, Ticel Bio Park Ii No.5, Csir Road, Taramani, Chennai, Tamil Nadu, 600113.
Athenese-Dx Private Limited was incorporated on 24 February 2012.
The current directors of Athenese-Dx Private Limited are
The primary industry of Athenese-Dx Private Limited is Manufacturing.
Athenese-Dx Private Limited is unlisted.
The authorized capital of Athenese-Dx Private Limited is ₹1.00 Cr, and the paid-up capital is ₹7.02 M.
The compliance status of Athenese-Dx Private Limited is Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX